
Thomas Altree
Adelaide Medical School
Faculty of Health and Medical Sciences
Dr Altree is a Respiratory and Sleep Physician and Researcher based at The Queen Elizabeth Hospital (TQEH). He is the Lead of TQEH Respiratory Clinical Trials Unit. His research covers a wide range of respiratory and sleep medicine topics.
I conduct clinically-relevant research into respiratory and sleep disorders. The pathophysiology and treatment of breathlessness is a specific focus of my research.
-
Appointments
Date Position Institution name 2024 - ongoing Senior Clinical Lecturer University of Adelaide 2024 - ongoing Senior Research Fellow Flinders University 2022 - ongoing Respiratory and Sleep Physician SA Health -
Awards and Achievements
Date Type Title Institution Name Country Amount 2023 Research Award New Investigator Award World Sleep Society United States - -
Education
Date Institution name Country Title 2024 Flinders University Australia PhD 2012 University of Adelaide Australia MBBS -
Certifications
Date Title Institution name Country 2019 FRACP Royal Australasian College of Physicians Australia
-
Journals
-
Book Chapters
Year Citation 2022 Altree, T. J., Catcheside, P. G., Mukherjee, S., & Eckert, D. J. (2022). Pharmacological Management of Sleep-Disordered Breathing. In Control of Breathing during Sleep (pp. 221-232). CRC Press.
DOI -
Conference Papers
Year Citation 2024 Fitton, J., Manners, J., Lechat, B., Loffler, K., Altree, T., Catcheside, P., . . . Eckert, D. (2024). AN INVESTIGATION OF RELATIONSHIPS BETWEEN SLEEP TIME AND QUALITY, PSYCHOLOGICAL AFFECT, AND EXERCISE PERFORMANCE IN ELITE CYCLISTS DURING THE TOUR DE FRANCE. In SLEEP MEDICINE Vol. 115 (pp. 245). ELSEVIER. 2024 Osman, A., Mukherjee, S., Loffler, K., Altree, T., Proctor, S., Adams, R., . . . Eckert, D. (2024). A SINGLE OVERNIGHT INFUSION OF TAK-925, A SELECTIVE OREXIN 2 RECEPTOR AGONIST, REDUCES OBSTRUCTIVE SLEEP APNEA SEVERITY. In SLEEP MEDICINE Vol. 115 (pp. 326). ELSEVIER. 2024 Osman, A., Mukherjee, S., Altree, T., Proctor, S., Adams, R., Nguyen, P., . . . Eckert, D. (2024). EFFECTS OF TAK-925 (DANAVOREXTON) A SELECTIVE OREXIN 2 RECEPTOR AGONIST ON UPPER AIRWAY COLLAPSIBILITY AND PHARYNGEAL MUSCLE ACTIVITY IN ADULTS WITH OBSTRUCTIVE SLEEP APNEA. In SLEEP MEDICINE Vol. 115 (pp. 348-349). ELSEVIER. 2024 Altree, T., Pinczel, A., Toson, B., Loffler, K., Hudson, A., Currow, D., . . . Eckert, D. (2024). THE EFFECTS OF LOW-DOSE MORPHINE ON SLEEP AND BREATHLESSNESS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED CONTROLLED TRIAL. In SLEEP MEDICINE Vol. 115 (pp. 393). ELSEVIER. 2023 Eckert, D. J., Toson, B., Loffler, K. A., Ekstrom, M. P., Currow, D., & Altree, T. J. (2023). Sleep Quality as a Novel Mediator of Reductions in Daytime Breathlessness With Low-dose Morphine in People With Chronic Obstructive Pulmonary Disease. In Abstracts of the American-Thoracic-Society International Conference (2023, ATS) as published in the American Journal of Respiratory and Critical Care Medicine Vol. 207 (pp. A6506-1). DC, Washington: American Thoracic Society.
DOI2022 Altree, T., Aishah, A., Loffler, K., Grunstein, R., & Eckert, D. (2022). Reboxetine improves pharyngeal collapsibility and respiratory control in obstructive sleep apnoea. In EUROPEAN RESPIRATORY JOURNAL Vol. 60 (pp. 2 pages). SPAIN, Barcelona: EUROPEAN RESPIRATORY SOC JOURNALS LTD.
DOI2022 Aishah, A., Tong, B., Osman, A., Donegan, M., Pitcher, G., Kwan, B., . . . Eckert, D. (2022). TARGETED COMBINATION THERAPY BASED ON ENDOTYPES RESOLVES OBSTRUCTIVE SLEEP APNOEA. In SLEEP MEDICINE Vol. 100 (pp. S279). ELSEVIER. 2022 Aishah, A., Tong, B. K., Osman, A. M., Donegan, M., Pitcher, G., Kwan, B., . . . Eckert, D. J. (2022). Endotype Targeted, Combination Therapy Resolves Obstructive Sleep Apnea. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 205 (pp. 1 page). CA, San Francisco: AMER THORACIC SOC. 2018 Altree, T., Bussell, L., Phan, N., & Johnston, S. (2018). SAFETY OF PRE-OPERATIVE PULMONARY FUNCTION TESTING IN LEFT MAIN CORONARY ARTERY DISEASE. In RESPIROLOGY Vol. 23 (pp. 116). WILEY. -
Conference Items
2024 |
Medical Research Future Fund: Optimising Screening Diagnosis and Management of Obstructive Sleep Apnoea - A randomised controlled trial of multi-night screening and diagnosis of obstructive sleep apnoea (OSA) to improve diagnostic test accessibility, accuracy and reduce costs ($1,996,310) |
- SIMPLIFI-OSA - A study to investigate the management of patients using limited-channel testing versus full polysomnography for identification of OSA ($1,995,310) | |
2022 |
Flinders Foundation Health Seed Grant - Reboxetine for OSA after upper airway surgery ($25000) |
2021 |
Flinders Health and Medical Research Institute HDR Grant - Morphine Metabolism in Chronic Obstructive Pulmonary Disease ($5000) |
I give annual lectures to the intern and year 3 medical school student cohorts at The Queen Elizabeth Hospital. I often give invited presentations on my research, such as:
Teaching old drugs new tricks: opioids, OSA and surgery. The Stanford University Sleep Surgery group meeting. Virtual: based at Stanford University, California. 29 May 2024.
Phenotypes in obstructive sleep apnea. The Society of Anesthesia and Sleep Medicine Annual Scientific Meeting. Virtual: based in San Diego, California. 7 October 2021
Vulnerability to postoperative complications in obstructive sleep apnea: the importance of phenotypes. The International Anesthesia Research Society webinar on sleep medicine. Virtual: based in San Francisco, California. 4 June 2021
Connect With Me
External Profiles